Amber IIsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-08-29
Share capital
200,000.00 PLN
Registered address
ul. Żwirki I Wigury 16A/Biuro 315, 02-092 Warszawa, Poland
Electronic delivery address
AE:PL-73315-25465-RAGWC-29

Financials

Revenue history (in k)

Financial insight

  • The statement flags a going concern risk. Na dzień 31 grudnia 2025 r. skumulowane straty wyniosły 1 720 414,99 zł i przewyższyły sumę kapitału zapasowego i kapitałów rezerwowych oraz połowę kapitału zakładowego o kwotę 1 458 699,19 zł. Stosownie do wymogów art. 233 ustawy z dnia 7.12.2023 r. KSH (Dz.U. z 2024 r. poz. 18) Nadzwyczajne Zgromadzenie Wspólników w dniu 6 marca 2026 podjęło uchwałę o kontynuowaniu działalności firmy.

From the notes

Current income tax (CIT due)$0

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 68 days for 2021).

  • 202515/07/2026
  • 202416/07/2025
  • 202314/07/2024
  • 202228/08/2023
  • 202121/09/2022
  • 202014/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 38%
Division · Retail trade2,617 / 9,915
Top 26%
City · Warszawa7,572 / 56,967
Top 13%
Voivodeship · Mazowieckie10,783 / 77,130
Top 14%
Country · Poland41,494 / 297,932
Top 14%

Results vs industry

Revenue
This companyUSD 3.64mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -40.83kMedianUSD 20.70kAverageUSD 86.94k
Operating costs
This companyUSD 3.61mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 783.81kMedianUSD 543.65kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Amber II has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 513.24. All its contracts were worth USD 3.08k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmesświętokrzyskie1USD 513.24

Authorized Representatives

Grzegorz Andrzej Bajtałaage 51 – President of the Management Board

Manner of representation

If the management board is a multi-member management board, the joint action of two members of the management board or one member of the management board jointly with a commercial proxy is required to submit declarations of will on behalf of the company. In the case of a one-person management board, the company is represented by the President of the Management Board independently.

Ownership

OwnerSharesShare valueStake
200$54,024.85100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2007-11-09.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 77,245

Public aid

34 public aid cases recorded, with a total value of $24,869.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cosmedicasp. z o.o.
DR ZdrowieS.A.
MagmaxS.A.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

Change history

DateEvent
2026-08-18PKD change
2023-10-11Address change
2023-10-11PKD change
2017-10-09Address change
2017-10-09PKD change

FAQ

Last updated: 2026-10-07